Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Mylan NV Ord Shs (MYL)

Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
WWE® Elects Michelle McKenna & JoEllen Lyons Dillon to Board of Directors Business Wire - Fri Sep 16, 2022

WWE ® (NYSE: WWE) today announced that Michelle McKenna and JoEllen Lyons Dillon have been elected to its Board of Directors.

RNG : 37.39 (-0.16%)
NSP : 75.78 (-0.43%)
VRTS : 218.34 (-1.20%)
MYL : 15.86 (+1.96%)
DM : 2.33 (-18.25%)
WWE : 100.65 (+2.65%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Investors who Formerly Held Shares of Mylan Inc. (MYL) to Contact the Firm Business Wire - Wed Sep 29, 2021

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Viatris Inc. (“Viatris” or “the Company”) (NASDAQ: VTRS...

MYL : 15.86 (+1.96%)
VTRS : 12.49 (-0.24%)
This July 2021 image provided by Viatris shows Semglee insulin. On Wednesday, July 28, 2021, U.S. regulators took action that will make it easier to get a cheaper and similar version of a brand-name insulin at the drugstore. The Food and Drug Administration agreed that Viatris Inc.’s Semglee was interchangeable with widely use Lantus, a fast-acting insulin. (Viatris via AP)
FDA allows automatic 'generic' swap for brand-name insulin Associated Press - Thu Jul 29, 2021

U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of a brand-name insulin at the drugstore.

MYL : 15.86 (+1.96%)

Barchart Exclusives

Navigating Uncertainty: What I'm Watching In The Grain Markets To Wrap Up 2024 Barchart - 5 minutes ago
From Brazil's economic woes to the future of biofuels, there is something for everyone as we end the year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot